6 research outputs found

    Sex effects on structural maturation of the limbic system and outcomes on emotional regulation during adolescence

    Get PDF
    Though adolescence is a time of emerging sex differences in emotions, sex-related differences in the anatomy of the maturing brain has been under-explored over this period. The aim of this study was to investigate whether puberty and sexual differentiation in brain maturation could explain emotional differences between girls and boys during adolescence. We adapted a dedicated longitudinal pipeline to process structural and diffusion images from 335 typically developing adolescents between 14 and 16 years. We used voxel-based and Regions of Interest approaches to explore sex and puberty effects on brain and behavioral changes during adolescence. Sexual differences in brain maturation were characterized by amygdala and hippocampal volume increase in boys and decrease in girls. These changes were mediating the sexual differences in positive emotional regulation as illustrated by positive attributes increase in boys and decrease in girls. Moreover, the differential maturation rates between the limbic system and the prefrontal cortex highlighted the delayed maturation in boys compared to girls. This is the first study to show the sex effects on the differential cortico/subcortical maturation rates and the interaction between sex and puberty in the limbic system maturation related to positive attributes, reported as being protective from emotional disorders.Peer reviewe

    Sex-specific associations between co-exposure to multiple metals and externalizing symptoms in adolescence and young adulthood

    Get PDF
    : Externalizing disorders, such as attention-deficit/hyperactivity disorder (ADHD), account for the majority of the child/adolescent referrals to mental health services and increase risk for later-life psychopathology. Although the expression of externalizing disorders is more common among males, few studies have addressed how sex modifies associations between metal exposure and adolescent externalizing symptoms. This study aimed to examine sex-specific associations between co-exposure to multiple metals and externalizing symptoms in adolescence and young adulthood. Among 150 adolescents and young adults (55% female, ages: 15-25 years) enrolled in the Public Health Impact of Metals Exposure (PHIME) study in Brescia, Italy, we measured five metals (manganese (Mn), lead (Pb), copper (Cu), chromium (Cr), nickel (Ni)) in four biological matrices (blood, urine, hair, and saliva). Externalizing symptoms were assessed using the Achenbach System of Empirically Based Assessment (ASEBA) Youth Self-Report (YSR) or Adult Self Report (ASR). Using generalized weighted quantile sum (WQS) regression, we investigated the moderating effect of sex (i.e., assigned at birth) on associations between the joint effect of exposure to the metal mixture and externalizing symptoms, adjusting for age and socioeconomic status. We observed that metal mixture exposure was differentially associated with aggressive behavior in males compared to females (β = -0.058, 95% CI [-0.126, -0.009]). In males, exposure was significantly associated with more externalizing problems, and aggressive and intrusive behaviors, driven by Pb, Cu and Cr. In females, exposure was not significantly associated with any externalizing symptoms. These findings suggest that the effect of metal exposure on externalizing symptoms differs in magnitude between the sexes, with males being more vulnerable to increased externalizing symptoms following metal exposure. Furthermore, our findings support the hypothesis that sex-specific vulnerabilities to mixed metal exposure during adolescence/young adulthood may play a role in sex disparities observed in mental health disorders, particularly those characterized by externalizing symptoms

    Investigating the neuroimmunomodulatory effects of 40Hz light flicker treatment in 5xFAD model of Alzheimer’s Disease

    Get PDF
    AD is a chronic neurodegenerative condition affecting the aging population. Recently there has been global concern due to the rising prevalence of the disease and increasing financial burden of care. Despite the increasing prevalence of Alzheimer’s Disease (AD) there are currently no non-invasive treatments available for patients, with all available therapies only targeting the symptoms of disease and not the cause. Recently, a potential new form of treatment for AD has been gaining interest due to its non-invasive properties. Several studies have found that flickering a light at a 40Hz frequency was capable of reducing the disease pathology and improve memory retention in mouse models of AD via an unknown mechanism. We sought to unveil some of the mechanisms of this potential therapy. Using previously published methods we investigated the ability of 40Hz flickering light to reduce amyloid-β (Aβ) in the brains of 5xFAD mice- a transgenic mouse model of AD. We first used 9-month-old animals and treated for 1 hour a day for either 5 consecutive days or 15 days. In these 9-month-old animals we observed no significant changes in Aβ pathology (either plaque area or number) within the visual cortex (VC). We then changed the format of our treatment and reduced the ages of our animals to 4-5 months and revised our treatment equipment. At this reduced age we observed a significant reduction in total Aβ area alongside changes in gene expression in the VC for genes associated with the Aβ processing pathway, such as endogenous mouse APP and γ-secretase protein PSEN1. We then examined if the 40Hz light-flicker exhibited sex-dependent responses as previous studies have not examined sex-based differences. We observed that while some genes showed consistent changes between the sexes (PSEN1 & mAPP) some genes exhibited significant differences between male and female 5xFAD mice (BACE1 & Cst7), suggesting that the response was sex-dependent. Thus, 40Hz light flicker treatment reduced expression of Aβ in 4- 5-month-old 5xFAD mice as well as inducing significant changes in gene expression within the VC.AD is a chronic neurodegenerative condition affecting the aging population. Recently there has been global concern due to the rising prevalence of the disease and increasing financial burden of care. Despite the increasing prevalence of Alzheimer’s Disease (AD) there are currently no non-invasive treatments available for patients, with all available therapies only targeting the symptoms of disease and not the cause. Recently, a potential new form of treatment for AD has been gaining interest due to its non-invasive properties. Several studies have found that flickering a light at a 40Hz frequency was capable of reducing the disease pathology and improve memory retention in mouse models of AD via an unknown mechanism. We sought to unveil some of the mechanisms of this potential therapy. Using previously published methods we investigated the ability of 40Hz flickering light to reduce amyloid-β (Aβ) in the brains of 5xFAD mice- a transgenic mouse model of AD. We first used 9-month-old animals and treated for 1 hour a day for either 5 consecutive days or 15 days. In these 9-month-old animals we observed no significant changes in Aβ pathology (either plaque area or number) within the visual cortex (VC). We then changed the format of our treatment and reduced the ages of our animals to 4-5 months and revised our treatment equipment. At this reduced age we observed a significant reduction in total Aβ area alongside changes in gene expression in the VC for genes associated with the Aβ processing pathway, such as endogenous mouse APP and γ-secretase protein PSEN1. We then examined if the 40Hz light-flicker exhibited sex-dependent responses as previous studies have not examined sex-based differences. We observed that while some genes showed consistent changes between the sexes (PSEN1 & mAPP) some genes exhibited significant differences between male and female 5xFAD mice (BACE1 & Cst7), suggesting that the response was sex-dependent. Thus, 40Hz light flicker treatment reduced expression of Aβ in 4- 5-month-old 5xFAD mice as well as inducing significant changes in gene expression within the VC

    Stress exposure from in-utero to adolescence, the HPA-axis response to stress, and symptoms of depression and anxiety in adulthood

    Get PDF
    This doctoral thesis used a prospective design in a series of four studies to investigate links between common early-life stress exposures, from in-utero to age 17, alterations in the HPA-axis physiological response to a stressor at age 18, and depression and anxiety symptoms at age 20, with consideration of sex differences. Findings are important as they may help inform the timing of intervention and support strategies for reducing exposure to early-life stress
    corecore